Dashboard
Poor long term growth as Operating profit has grown by an annual rate -182.98% of over the last 5 years
Negative results in Mar 26
Stock is technically in a Mildly Bearish range
Risky - Negative Operating Profits
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 553 Cr (Micro Cap)
NA (Loss Making)
42
0.31%
0.29
0.82%
1.47
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Valuation Shifts Signal Heightened Price Risk
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has seen a marked deterioration in its valuation parameters, signalling increased price risk for investors. The company’s price-to-earnings (P/E) ratio has plunged to a deeply negative -206.02, while its price-to-book value (P/BV) has risen to 1.74, pushing its valuation grade from expensive to very expensive. This shift comes amid a backdrop of weak profitability and subdued returns on capital, raising questions about the stock’s price attractiveness relative to peers and historical benchmarks.
Read More
Chemfab Alkalis Ltd Valuation Shifts to Very Expensive Amid Mixed Returns
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating. Despite a modest day change of 0.05% and a current price of ₹395.00, the company’s price-to-earnings (P/E) ratio and other valuation metrics reveal a complex picture that investors must carefully analyse amid mixed returns and sector dynamics.
Read More
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Jun-2026 | Source : BSESubmission of copy of newspaper publication wrt. SEBI circular dated 30th Jan 2026 on special window for transfer and dematerialisation of physical securities.
Compliances-Reg.24(A)-Annual Secretarial Compliance
26-May-2026 | Source : BSEDear Sir/Mam Please find enclosed Annual Secretarial Compliance Report for the financial Year ended 31st March 2026
Announcement under Regulation 30 (LODR)-Acquisition
20-May-2026 | Source : BSESubmission of Letter dated 20th May 2026 regarding investment by the Company in Zenataris Renewable Energy Private Limited. Kindly take the same on record.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.04%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.63%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024